Micardis
Micardis®
(telmisartan) Tablets, 20 mg, 40 mg and 80 mg
USE IN PREGNANCY
When used in pregnancy during the second and third trimesters, drugs that act directly on the renin- angiotensin system can cause injury and even death to the developing fetus. When pregnancy is detected, MICARDIS® tablets should be discontinued as soon as possible.
See WARNINGS: Fetal/Neonatal Morbidity and Mortality
DRUG DESCRIPTION
MICARDIS® (telmisartan) is a nonpeptide angiotensin II receptor (type AT1) antagonist.
Telmisartan is chemically described as 4'-[(1,4'-dimethyl-2'-propyl [2,6'-bi-1H-benzimidazol]-1'- yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid. Its empirical formula is C33H30N4O2, its molecular weight is 514.63, and its structural formula is:
![]() |
Telmisartan is a white to slightly yellowish solid. It is practically insoluble in water and in the pH range of 3 to 9, sparingly soluble in strong acid (except insoluble in hydrochloric acid), and soluble in strong base.
MICARDIS is available as tablets for oral administration, containing 20 mg, 40 mg or 80 mg of telmisartan. The tablets contain the following inactive ingredients: sodium hydroxide, meglumine, povidone, sorbitol, and magnesium stearate. MICARDIS tablets are hygroscopic and require protection from moisture.
Generic Name: Telmisartan
Hypertension
Get tips on handling your hypertension.
Soy for High Blood Pressure
About 65 million Americans have high blood pressure and more and more are turning to alternative therapies. Here, we look at soy. See more WebMD Videos »


